Why the study?
With increasing anticoagulant use worldwide, clinicians frequently encounter scenarios requiring anticoagulant withholding or reversal, such as procedures or bleeding, necessitating an understanding of reversal strategies and reinitiation timing.
Key points are not available for this paper at this time.
Design
Review article
May guide ICU anticoagulant reversal decisions; leaves open need for prospective validation of protocols.
There has seen an increase in anticoagulant consumption worldwide over the past few decades. With this widespread utilization of anticoagulants, clinicians are increasingly likely to encounter situations where anticoagulants would need to be withheld. This includes emergency and elective procedures or surgeries as well as major or minor bleeding as a direct result of over anticoagulation or consequent to other intercurrent illnesses such as sepsis or trauma with multiorgan failure, where the anticoagulant may contribute to coagulation abnormalities. Clinicians are required to have a thorough understanding of the indications for anticoagulant prescription, drug interactions and monitoring, indications and options of reversal of anticoagulation and management of bleeding in the situations described above. Once the acute process is managed, the ongoing need and timing of reinitiation of anticoagulation is also crucial. This article provides an overview on the indications for reversal of anticoagulation, the agents used for reversal and the timing of reinitiation of anticoagulants. HOW TO CITE THIS ARTICLE: Chacko B, Peter JV, Subramani K. Reversal of Anticoagulants in Critical Care. Indian J Crit Care Med 2019;23(Suppl 3):S221-S225.
No takes yet. Share an insight, caveat, or question.
John Victor Peter (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: